Comparison between Ki-67 biomarker expression in primary breast cancer before and after neoadjuvant therapy.

被引：0
|
作者：
Zidan, Jamal [1 ]
机构：
[1] Ziv Med Ctr, Inst Oncol, Safed, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24311
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer
    Iwata, Hiroji
    Masuda, Norikazu
    Sagara, Yasuaki
    Kinoshita, Takayuki
    Nakamura, Seigo
    Yanagita, Yasuhiro
    Nishimura, Reiki
    Iwase, Hirotaka
    Kamigaki, Shunji
    Takei, Hiroyuki
    Tsuda, Hitoshi
    Hayashi, Nobuya
    Noguchi, Shinzaburo
    CANCER, 2013, 119 (04) : 704 - 713
  • [42] Quantitative Ki-67 score as predictive of response to neoadjuvant chemotherapy in breast cancer
    Brown, Jason R.
    Lannin, Donald R.
    Killelea, Brigid K.
    DiGiovanna, Michael
    Rimm, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
    Magnusson, Kristina
    Gremel, Gabriela
    Ryden, Lisa
    Ponten, Victor
    Uhlen, Mathias
    Dimberg, Anna
    Jirstrom, Karin
    Ponten, Fredrik
    BMC CANCER, 2016, 16
  • [44] Correlation between FLT-PET and Ki-67 change in breast cancer during neoadjuvant chemotherapy
    Blackman, S. C.
    Railkar, R. A.
    Fox, R.
    George, L.
    Iannone, R.
    Bergstrom, D. A.
    Mozley, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] The expression and significance of Ki-67 in the primary tumour and lymph nodes metastases in breast cancer patients
    Kometova, V.
    Rodionov, V.
    Dergunova, Y.
    Rodionova, M.
    VIRCHOWS ARCHIV, 2016, 469 : S50 - S50
  • [46] Expression of ERα, ERβ and Ki-67 in primary tumors and lymph node metastases in breast cancer
    Koda, M
    Sulkowski, S
    Kanczuga-Koda, L
    Surmacz, E
    Sulkowska, M
    ONCOLOGY REPORTS, 2004, 11 (04) : 753 - 759
  • [47] Comparison of Ki-67 expression using five different clones in core biopsy samples of breast cancer patients undergoing neoadjuvant chemotherapy
    Szasz, A. M.
    Kulka, J.
    Agoston, E.
    Teleki, I.
    Krenacs, T.
    Tokes, A-M
    Riemenschnitter, C.
    Keszthelyi, R.
    Szekeres, G.
    Moch, H.
    Varga, Z.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 267 - 267
  • [48] Recurrence and survival in early breast cancer in relation to Ki-67 expression
    Gerson-Cwilich, Raquel
    Alban-de la Torre, Luis Fernando
    Villalobos-Prieto, Alberto
    Lezid Padilla-Rodriguez, Alvaro
    Alberto Serrano-Olvera, Juan
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (01): : 4 - 11
  • [49] Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy
    Liebscher, Sean C.
    Kilgore, Lyndsey J.
    Winblad, Onalisa
    Gloyeske, Nika
    Larson, Kelsey
    Balanoff, Christa
    Nye, Lauren
    O'Dea, Anne
    Sharma, Priyanka
    Kimler, Bruce
    Khan, Qamar
    Wagner, Jamie
    HEALTHCARE, 2023, 11 (03)
  • [50] Use of ultrasound and Ki-67 Proliferation Index to predict breast cancer tumor response to neoadjuvant endocrine therapy
    Liebscher, Sean
    Wagner, Jamie
    Khan, Qamar
    Winblad, Onalisa
    Gloyeske, Nika
    Balanoff, Christa
    Larson, Kelsey
    Nye, Lauren
    O'Dea, Anne
    Sharma, Priyanka
    Kimler, Bruce
    Kilgore, Lyndsey
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 149 - 149
12345